Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


GIMV sells its stake in Hypnion

Following the earlier release of 5 March 2007, GIMV announces that it has sold its stake in drug discovery and development company Hypnion ( to Eli Lilly & Company ( Hypnion is a privately owned neuroscience drug discovery and development company that is focused on sleep disorders. Last January, Hypnion announced that its compound HY10275 met the primary and secondary endpoints in the company’s initial phase II clinical trials.

Eli Lilly acquired Hypnion for a total amount of USD 315 million. GIMV was a minority shareholder of Hypnion since 2000, took part in both the Series-A and Series-B financing rounds, and now sells its stake in Hypnion together with all other shareholders to Eli Lilly & Company.

The sale has a positive impact of EUR 12.4 million (EUR 0.53 per share) on GIMV’s last published equity value at 31 December 2006.

Since its incorporation in 1980 GIMV has grown into Belgium's most important venture capital provider and companybuilder. GIMV has now become a major European and international market player. Both in Belgium and abroad, GIMV invests in information and communication technology, life sciences as well as in growth financing and management buyouts (MBOs) of companies in more traditional sectors. GIMV currently manages around EUR 1.5 billion of assets (including third party funds). GIMV has been listed on Euronext Brussels since 1997.
For more information on GIMV, please go to

Publisher Contact Information:

+32 3 290 22 18

Company profile of GIMV N.V.
Past press releases of GIMV N.V. .


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Sep 20€8.0MSecurity
Sep 20€3.0MArtificial Intelligence
Sep 20€55.0MInternet services
Sep 20€1.0MContent management
Sep 19€23.0MKnowledge management
Sep 19€2.3MKnowledge management
Sep 19€15.0MDiagnostics

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.